NO920461L - Fremgangsmaate for fremstilling av en med technetium-99m markert organspesifikk substans - Google Patents

Fremgangsmaate for fremstilling av en med technetium-99m markert organspesifikk substans

Info

Publication number
NO920461L
NO920461L NO92920461A NO920461A NO920461L NO 920461 L NO920461 L NO 920461L NO 92920461 A NO92920461 A NO 92920461A NO 920461 A NO920461 A NO 920461A NO 920461 L NO920461 L NO 920461L
Authority
NO
Norway
Prior art keywords
technetium
specific substance
procedure
manufacturing
organ specific
Prior art date
Application number
NO92920461A
Other languages
English (en)
Norwegian (no)
Other versions
NO920461D0 (no
Inventor
Ludwig Kuhlmann
Anton Mayer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO920461D0 publication Critical patent/NO920461D0/no
Publication of NO920461L publication Critical patent/NO920461L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NO92920461A 1991-02-05 1992-02-04 Fremgangsmaate for fremstilling av en med technetium-99m markert organspesifikk substans NO920461L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4103370 1991-02-05

Publications (2)

Publication Number Publication Date
NO920461D0 NO920461D0 (no) 1992-02-04
NO920461L true NO920461L (no) 1992-08-06

Family

ID=6424382

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92920461A NO920461L (no) 1991-02-05 1992-02-04 Fremgangsmaate for fremstilling av en med technetium-99m markert organspesifikk substans

Country Status (9)

Country Link
US (2) US5863517A (fi)
EP (1) EP0498333B1 (fi)
JP (1) JP3549115B2 (fi)
AT (1) ATE147637T1 (fi)
DE (1) DE59207867D1 (fi)
ES (1) ES2098382T3 (fi)
FI (1) FI920459A (fi)
IE (1) IE920359A1 (fi)
NO (1) NO920461L (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4578425B2 (ja) * 2006-03-20 2010-11-10 行政院原子能委員會核能研究所 テクネチウム−９９ｍ過テクネチウム酸溶液の濃縮装置及びその方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987157A (en) * 1974-08-29 1976-10-19 Union Carbide Corporation Technetium 99-m labeled radio-diagnostic agents employing stannous tartrate and method of preparation
US4293537A (en) * 1978-09-05 1981-10-06 Wong Dennis W Novel chemical method of labeling proteins with 99m Tc-Technetium at physiological condition
US4424200A (en) * 1979-05-14 1984-01-03 Nuc Med Inc. Method for radiolabeling proteins with technetium-99m
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
DE3237573A1 (de) * 1982-10-09 1984-04-12 Hoechst Ag, 6230 Frankfurt Technetium-99m-tri- und tetraphosphonate zur szintigraphischen dastellung res-haltiger organe und der lymphgefaesse und verfahren zu deren herstellung
US4652440A (en) * 1984-05-03 1987-03-24 Paik Chang H Method of stably radiolabeling antibodies with technetium and rhenium
US5175343A (en) * 1985-01-14 1992-12-29 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
US5164175A (en) * 1986-12-10 1992-11-17 Hoechst Aktiengesellschaft Diagnostic aid containing an organ-specific substance labeled with technetium-99m
DE3728599A1 (de) * 1986-12-10 1988-06-23 Hoechst Ag Verfahren zur herstellung einer mit technetium-99m-markierten organspezifischen substanz
DE3850497T2 (de) * 1987-04-02 1995-02-23 Centocor Inc Methode zur markierung von antikörpern mit einem metallion.
US5053493A (en) * 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
US5021556A (en) * 1987-07-22 1991-06-04 Neorx Corporation Method of radiolabeling chelating compounds comprising sulfur atoms with metal radionuclides
DE3728600A1 (de) * 1987-08-27 1989-03-09 Hoechst Ag Verfahren zur markierung von substanzen mit technetium oder rhenium
ATE124269T1 (de) * 1988-02-09 1995-07-15 Mallinckrodt Inc Verfahren zur herstellung eines mit metall- radionuklid-markierten proteins.
US5061641A (en) * 1988-04-01 1991-10-29 Immunomedics, Inc. Method for radiolabeling proteins
US5128119A (en) * 1989-06-12 1992-07-07 Immunomedics, Inc. Methods for technetium/rhenium labeling of f(ab1)2 fragments
US5078985A (en) * 1989-08-09 1992-01-07 Rhomed, Incorporated Radiolabeling antibodies and other proteins with technetium or rhenium by regulated reduction
US5102990A (en) * 1989-08-09 1992-04-07 Rhomed Incorporated Direct radiolabeling of antibodies and other proteins with technetium or rhenium
CA1340250C (en) * 1989-09-18 1998-12-15 Hans J. Hansen Method for rapidly radiolabeling monovalent antibody fragments with technetium
US5011676A (en) * 1990-03-27 1991-04-30 Thomas Jefferson University Method to directly radiolabel antibodies for diagnostic imaging and therapy

Also Published As

Publication number Publication date
NO920461D0 (no) 1992-02-04
ATE147637T1 (de) 1997-02-15
EP0498333B1 (de) 1997-01-15
EP0498333A2 (de) 1992-08-12
FI920459A (fi) 1992-08-06
US5863517A (en) 1999-01-26
ES2098382T3 (es) 1997-05-01
JPH0585944A (ja) 1993-04-06
JP3549115B2 (ja) 2004-08-04
EP0498333A3 (en) 1992-11-19
IE920359A1 (en) 1992-08-12
US6090366A (en) 2000-07-18
FI920459A0 (fi) 1992-02-03
DE59207867D1 (de) 1997-02-27

Similar Documents

Publication Publication Date Title
FI925270A0 (fi) Farmaceutiska preparat foer oral anvaendning samt foerfarande foer deras framstaellning
SE8302693D0 (sv) Heterocyclische verbindungen
ATE142341T1 (de) Bindung von liganden an gold
ATE390933T1 (de) Aus immunisierten xenomäusen stammende menschliche antikörper gegen il-8
DK0641222T3 (da) Peptider mærket med technetium-99m til trombeafbildning
BR8203771A (pt) Processo para preparacao de um composto e composicoes detergentes contendo o mesmo
UA32577C2 (uk) Радіомічена сполука для утворення зображення тромбів при радіонуклідній діагностиці, радіофармацевтичний препарат та радіофармацевтична композиція на їх основі та комплект для приготування радіофармацевтичних препаратів
DK0435443T3 (da) Anvendelse af en 15-ketoprostaglandinforbindelse til forbedring af den encephaliske funktion
DE69520256T2 (de) Chelatbildende Gruppen enthaltende Somastotatin-Analoge und deren radiomarkierteZusammensetzungen
IN173187B (fi)
DE3684211D1 (fi)
DK407987A (da) Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer
ATE234639T1 (de) Technetium-99m markierte bildformungsmittel
NO920461D0 (no) Fremgangsmaate for fremstilling av en med technetium-99m markert organspesifikk substans
ES2114547T3 (es) Anticuerpos monoclonales contra el virus de la hepatitis c.
IL64157A (en) Tridecapeptide compounds and their preparation
DE69117453D1 (de) Verfahren und Vorrichtung zur Markierung von Materialien, insbesondere monoklonalen Antikörpern, mit Radioisotopen bei gleichzeitiger Reinigung des Materials von ungebrauchten Isotopen
NO159905C (no) Herdbar bindemiddelblanding for formbare stoepeblandinger.
DE3063755D1 (en) Technetium-99m labeled acetanilidoiminodiacetates for liver function diagnosis and process for their preparation
DK0513565T3 (da) Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse
ES2053704T3 (es) Un metodo de estabilizacion de una composicion acuosa consistente en uno o mas anticuerpos monoclonales.
DE69117741D1 (de) Neue vorangeordnete sechszähnige liganden verwendbar in röntgenologischen bildformenden wirkstoffen
YU17890A (sh) Tekoc, algicidno ucinkovit pripravek
DK0488778T3 (da) Radioaktiv iodforbindelse til mærkning af antistof
SE8602271D0 (sv) Ett sett att se atommolekyler pa enkel sett